What Moves Like RPRX

Royalty Pharma plc - Class A Ordinary Shares Pharmaceutical Preparations · Nasdaq

The tradable tickers whose daily moves track RPRX most closely over the past year, filtered to risk comparable with RPRX's own.

Closest match

FTXH First Trust Nasdaq Pharmaceuticals ETF — 0.678 correlation over the past year, and 16% calmer than RPRX.

About RPRX

Annualised volatility 22.1%
Beta vs SPY 0.22
Market correlation 0.136
Traded per day $167.9M
Rate sensitivity -0.36
Volatility sensitivity -0.12

As filed with the SEC twelve months to 2025-12-31 · balance sheet 2026-03-31

Revenue $2.38B
Operating income $1.56B
Net income $770.9M
Diluted EPS $1.78
Total assets $19.82B
Total liabilities $9.88B
Cash & equivalents $586.4M
251 sessions to 2026-11-09 · RPRX volatility 22.1% annualised · $167.9M a day
Ticker 1-year correlation 3-year Volatility vs RPRX Risk What it is
FTXH First Trust Nasdaq Pharmaceuticals ETF
0.678
0.478 0.84× 16% calmer Fund
PPH VanEck Pharmaceutical ETF
0.647
0.454 0.86× 14% calmer Fund
IXJ iShares Global Healthcare ETF
0.641
0.455 0.75× 25% calmer Fund
PJP Invesco Pharmaceuticals ETF
0.639
0.429 0.83× 17% calmer Fund
IHE iShares U.S. Pharmaceutical ETF
0.639
0.472 0.87× 13% calmer Fund
IYH iShares U.S. Healthcare ETF
0.634
0.448 0.78× 23% calmer Fund
FHLC Fidelity MSCI Health Care Index ETF
0.634
0.450 0.75× 25% calmer Fund
XLV State Street Health Care Select Sector SPDR ETF
0.632
0.447 0.77× 23% calmer Fund
VHT Vanguard Health Care ETF
0.629
0.451 0.75× 25% calmer Fund
AMGN Amgen Inc.
0.587
0.364 1.32× 32% choppier Biological Products, (No Diagnostic Substances)
BBH VanEck Biotech ETF
0.586
0.430 1.04× similar Fund
NVS Novartis AG
0.561
0.397 1.23× 23% choppier Pharmaceutical Preparations
IBBQ Invesco Nasdaq Biotechnology ETF
0.559
0.403 1.06× similar Fund
BMY Bristol-Myers Squibb Company
0.557
0.356 1.27× 27% choppier Pharmaceutical Preparations
IBB iShares Biotechnology ETF
0.537
0.396 1.07× similar Fund
FXH First Trust Health Care AlphaDEX
0.537
0.418 0.77× 23% calmer Fund
GSK GSK plc American Preferred
0.535
0.348 1.19× 19% choppier Pharmaceutical Preparations
BME Blackrock Health Sciences Trust
0.529
0.376 0.66× 34% calmer —
RSPH Invesco S&P 500 Equal Weight Health Care ETF
0.518
0.409 0.80× 21% calmer Fund
THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
0.517
0.365 0.87× 13% calmer —
INCY Incyte Corporation
0.511
0.304 1.51× 51% choppier Services-Commercial Physical & Biological Research
MRK Merck & Company, Inc. Common Stock (new)
0.503
0.344 1.37× 37% choppier Pharmaceutical Preparations
FBT First Trust Amex Biotech Index Fund
0.501
0.398 1.02× similar Fund
ABBV AbbVie Inc.
0.500
0.295 1.16× 16% choppier Pharmaceutical Preparations
GILD Gilead Sciences, Inc.
0.495
0.343 1.25× 25% choppier Biological Products, (No Diagnostic Substances)

Showing 25 of 30 tickers that qualified. Correlation is of daily returns; 1.000 would mean moving in lockstep, 0.000 no relationship at all.

What this is for

Three questions, one number behind all of them.

How to read the two correlation columns

The one-year figure is what the relationship looks like now. The three-year figure is what it has looked like over a longer stretch. Comparing them is the point: when they agree, the relationship is structural and likely to hold. When the one-year number is far below the three-year one, something has changed — a shift in business mix, an index reconstitution, a sector that has stopped moving together — and the recent figure is the one to trust less, not more.

Correlation measures whether two things move together, not whether they move by the same amount. That is why the volatility column is there. Two tickers can correlate at 0.99 while one swings half again as hard, and swapping one for the other would quietly change how much risk you are carrying.

What was deliberately left out

Ranking purely by correlation produces answers that are mathematically perfect and practically useless. The closest matches to AAPL by raw correlation are leveraged AAPL funds at 0.999 — correct, and not replacements for anything. Four filters run before a ticker is allowed to appear:

Where all of that leaves a ticker with no close match, the page says so. A stock with no substitute is a real and useful finding, and inventing a loose one to fill the table would be worse than an empty answer.

Limits, stated up front

Where the numbers come from

Correlations are computed in-house from a daily price history and rebuilt every night. What gets published is the derived statistic — a correlation coefficient, a volatility ratio, an observation count — and nothing from which a price or return series could be reconstructed. The rest of the Markets section is on the Markets overview, including futures positioning extremes and SEC Form 4 insider transactions.